For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Bind Therapeutics, Inc.

USPTO Granted Patents = 27

CIPO Patents = 4

EPO Patents = 3

Forward Citations = 1,318

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Greg Troiano (20 out of 41 patents)

Stephen E Zale (20 out of 50 patents)

Mir Mukkaram Ali (16 out of 27 patents)

4. James I Wright (16 out of 58 patents)

5. Jeff Hrkach (10 out of 17 patents)

6. Young-Ho Song (6 out of 19 patents)

7. Christina Van Geen Hoven (6 out of 13 patents)

8. Michael Figa (6 out of 9 patents)

9. Abhimanyu Sabnis (6 out of 9 patents)

10. David Dewitt (5 out of 10 patents)

11. Maria Figueiredo (2 out of 6 patents)

12. Jason Auer (2 out of 2 patents)

13. Tarikh Christopher Campbell (2 out of 2 patents)

14. Amy Grayson (2 out of 2 patents)

15. Hong Wang (0 patent)

27 patents: Sort by Forward Citations

1. 9393310 - Drug loaded polymeric nanoparticles and methods of making and using same (2016-07-19),

2. 9375481 - Drug loaded polymeric nanoparticles and methods of making and using same (2016-06-28),

3. 9358215 - High throughput fabrication of nanoparticles (2016-06-07),

4. 9351933 - Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same (2016-05-31),

5. 9308179 - Long circulating nanoparticles for sustained release of therapeutic agents (2016-04-12),

6. 9295727 - Cancer cell targeting using nanoparticles (2016-03-29),

7. 9295649 - Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers (2016-03-29),

8. 9198874 - Long circulating nanoparticles for sustained release of therapeutic agents (2015-12-01),

9. 8956657 - Stable formulations for lyophilizing therapeutic particles (2015-02-17),

10. 8916203 - Stable formulations for lyophilizing therapeutic particles (2014-12-23),

11. 8912212 - Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers (2014-12-16),

12. 8905997 - Therapeutic particles suitable for parenteral administration and methods of making and using same (2014-12-09),

13. 8663700 - Drug loaded polymeric nanoparticles and methods of making and using same (2014-03-04),

14. 8652528 - Drug loaded polymeric nanoparticles and methods of making and using same (2014-02-18),

15. 8637083 - Stable formulations for lyophilizing therapeutic particles (2014-01-28),

BIND Therapeutics, Inc. is a biotechnology company focused on the development of targeted therapeutics for the treatment of cancer. They leverage their proprietary Medicinal Nanoengineering platform to design and develop nanoparticle-based medicines. These targeted therapies aim to selectively deliver drugs to cancer cells, minimizing the impact on healthy cells and potentially enhancing treatment efficacy. BIND Therapeutics is dedicated to advancing innovative cancer treatments and improving patient outcomes through their cutting-edge technologies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

27 Patents

#84 in Cambridge, MA

#710 in Massachusetts

#11,980 in US

#23,234 in the World

Cambridge, MA, United States of America

Bind Therapeutics, Inc.

Forward Citations = 1,318

17 inventors:

Greg Troiano (20 out of 41 patents)

Stephen E Zale (20 out of 50 patents)

Mir Mukkaram Ali (16 out of 27 patents)

4. James I Wright (16 out of 58 patents)

5. Jeff Hrkach (10 out of 17 patents)

Please report any incorrect information to support@idiyas.com

Loading…